The purpose of this study is to determine if Pemafibrate (administered to participants as part of the PROMINENT study) prevents the worsening of diabetic retinopathy or reduces the incidence of diabetic macular edema.
Visit ClinicalTrials.gov for more information.
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.